SS
QTTB icon

SBI Securities’s Q32 Bio QTTB Stock Holding History

SBI Securities’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2K Sell
94
-10
-10% -$84 ﹤0.01% 2732
2026
Q1 		$668 Sell
104
-53
-34% -$252 ﹤0.01% 2792
2025
Q4 		$521 Sell
157
-7,999
-98% -$22.6K ﹤0.01% 2862
2025
Q3 		$16.1K Buy
8,156
+1
+0% +$2 ﹤0.01% 1542
2025
Q2 		$12.2K Buy
8,155
+8,008
+5,448% +$13.7K ﹤0.01% 1620
2025
Q1 		$243 Sell
147
-91
-38% -$245 ﹤0.01% 3150
2024
Q4 		$819 Buy
+238
New +$7.51K ﹤0.01% 2698

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's QTTB Position: Q2 2026 in Review

SBI Securities reduced its Q32 Bio (QTTB) stake by 9.6% in Q2 2026, selling an estimated $84 and leaving 94 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

SBI Securities first reported a position in QTTB in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.1K in Q3 2025. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • SBI Securities held 94 shares of Q32 Bio worth $1.2K as of Q2 2026.
  • SBI Securities sold 10 Q32 Bio shares in Q2 2026, an estimated $84.
  • Q32 Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2732 holding.
  • SBI Securities first reported a position in Q32 Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Q32 Bio position peaked at $16.1K in Q3 2025.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.